Literature DB >> 22481140

Immunization strategies against henipaviruses.

Christopher C Broder1, Thomas W Geisbert, Kai Xu, Dimitar B Nikolov, Lin-Fa Wang, Deborah Middleton, Jackie Pallister, Katharine N Bossart.   

Abstract

Hendra virus and Nipah virus are recently discovered and closely related emerging viruses that now comprise the genus henipavirus within the sub-family Paramyxoviridae and are distinguished by their broad species tropism and in addition to bats can infect and cause fatal disease in a wide variety of mammalian hosts including humans. The high mortality associated with human and animal henipavirus infections has highlighted the importance and necessity of developing effective immunization strategies. The development of suitable animal models of henipavirus infection and pathogenesis has been critical for testing the efficacy of potential therapeutic approaches. Several henipavirus challenge models have been used and recent successes in both active and passive immunization strategies against henipaviruses have been reported which have all targeted the viral envelope glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22481140      PMCID: PMC4465348          DOI: 10.1007/82_2012_213

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  93 in total

1.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus.

Authors:  H A Westbury; P T Hooper; P W Selleck; P K Murray
Journal:  Aust Vet J       Date:  1995-07       Impact factor: 1.281

4.  The lesions of experimental equine morbillivirus disease in cats and guinea pigs.

Authors:  P T Hooper; H A Westbury; G M Russell
Journal:  Vet Pathol       Date:  1997-07       Impact factor: 2.221

5.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

6.  A golden hamster model for human acute Nipah virus infection.

Authors:  K Thong Wong; Isabelle Grosjean; Christine Brisson; Barissa Blanquier; Michelle Fevre-Montange; Arlette Bernard; Philippe Loth; Marie-Claude Georges-Courbot; Michelle Chevallier; Hideo Akaoka; Philippe Marianneau; Sai Kit Lam; T Fabian Wild; Vincent Deubel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.

Authors:  Thomas A Bowden; A Radu Aricescu; Robert J C Gilbert; Jonathan M Grimes; E Yvonne Jones; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2008-05-18       Impact factor: 15.369

8.  Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat.

Authors:  Bruce A Mungall; Deborah Middleton; Gary Crameri; Kim Halpin; John Bingham; Bryan T Eaton; Christopher C Broder
Journal:  J Infect Dis       Date:  2007-08-14       Impact factor: 5.226

9.  Identifying Hendra virus diversity in pteropid bats.

Authors:  Ina Smith; Alice Broos; Carol de Jong; Anne Zeddeman; Craig Smith; Greg Smith; Fred Moore; Jennifer Barr; Gary Crameri; Glenn Marsh; Mary Tachedjian; Meng Yu; Yu Hsin Kung; Lin-Fa Wang; Hume Field
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

10.  Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007.

Authors:  Stephen P Luby; M Jahangir Hossain; Emily S Gurley; Be Nazir Ahmed; Shakila Banu; Salah Uddin Khan; Nusrat Homaira; Paul A Rota; Pierre E Rollin; James A Comer; Eben Kenah; Thomas G Ksiazek; Mahmudur Rahman
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more
  12 in total

1.  A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Authors:  Katharine N Bossart; Barry Rockx; Friederike Feldmann; Doug Brining; Dana Scott; Rachel LaCasse; Joan B Geisbert; Yan-Ru Feng; Yee-Peng Chan; Andrew C Hickey; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

Review 2.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

3.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

Review 4.  The Immunobiology of Nipah Virus.

Authors:  Yvonne Jing Mei Liew; Puteri Ainaa S Ibrahim; Hui Ming Ong; Chee Ning Chong; Chong Tin Tan; Jie Ping Schee; Raúl Gómez Román; Neil George Cherian; Won Fen Wong; Li-Yen Chang
Journal:  Microorganisms       Date:  2022-06-06

Review 5.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

Review 6.  Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.

Authors:  James Logue; Ian Crozier; Peter B Jahrling; Jens H Kuhn
Journal:  Expert Rev Vaccines       Date:  2020-01-30       Impact factor: 5.683

7.  Detailed morphological characterisation of Hendra virus infection of different cell types using super-resolution and conventional imaging.

Authors:  Paul Monaghan; Diane Green; Jackie Pallister; Reuben Klein; John White; Catherine Williams; Paul McMillan; Leann Tilley; Marko Lampe; Pippa Hawes; Lin-Fa Wang
Journal:  Virol J       Date:  2014-11-27       Impact factor: 4.099

Review 8.  Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.

Authors:  Raj Kumar Singh; Kuldeep Dhama; Sandip Chakraborty; Ruchi Tiwari; Senthilkumar Natesan; Rekha Khandia; Ashok Munjal; Kranti Suresh Vora; Shyma K Latheef; Kumaragurubaran Karthik; Yashpal Singh Malik; Rajendra Singh; Wanpen Chaicumpa; Devendra T Mourya
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

Review 9.  Henipavirus Encephalitis: Recent Developments and Advances.

Authors:  Kien Chai Ong; Kum Thong Wong
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

10.  Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.

Authors:  Eric D Laing; Moushimi Amaya; Chanakha K Navaratnarajah; Yan-Ru Feng; Roberto Cattaneo; Lin-Fa Wang; Christopher C Broder
Journal:  Virol J       Date:  2018-03-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.